5-Amino-1MQ

5-Amino-1MQ is a synthetic small molecule used in experimental research involving nicotinamide N-methyltransferase, cellular methyl-donor metabolism, adipocyte biology, and metabolic regulation.

Proposed to inhibit nicotinamide N-methyltransferase, an enzyme involved in nicotinamide metabolism and methyl-group balance. Downstream effects have been studied in cellular and animal metabolic models.

Predominantly preclinical.

Level IV, Predominantly preclinical

Human pharmacokinetic, toxicology, and controlled efficacy data are limited or absent. It is not a peptide despite frequent placement in peptide catalogs.

The human safety profile is not established. Potential off-target effects, dose-response relationships, and long-term toxicology remain uncertain.

Investigational research chemical; no FDA-approved drug product.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.